Protecting the Next Generation: The Global Rise of Nicotine Pouches

As we approach World No Tobacco Day on May 31, the global health community is sounding the alarm on a concerning trend: the rapid expansion of nicotine pouch products. While tobacco use remains a leading cause of preventable death, the industry is increasingly shifting its focus toward modern, discreet nicotine delivery systems that are being aggressively marketed to adolescents and young adults.

The Growing Threat of Nicotine Addiction

According to the World Health Organization (WHO), at least 40 million children aged 13–15 currently use tobacco products. The rise of e-cigarettes and nicotine pouches—small sachets placed between the gum and lip—is creating a new wave of nicotine addiction. These products deliver nicotine through the lining of the mouth and often contain sweeteners, flavorings, and other additives designed to mask the harshness of the chemical.

The primary concern for medical professionals is the impact on brain development. Nicotine is highly addictive, and exposure during adolescence can interfere with the development of the brain, potentially leading to learning disorders and long-term health risks. Dr. Etienne Krug, Director of the Department of Health Determinants, Promotion and Prevention at the WHO, has noted that major tobacco companies are reinventing their business models, continuing to profit from traditional cigarettes while aggressively pushing these newer, flavored products to hook the next generation.

Marketing Tactics Targeting Youth

The appeal of nicotine pouches is often manufactured through sophisticated marketing strategies. Industry tactics frequently mirror those used for e-cigarettes, including:

• Lifestyle Branding: Utilizing social media influencers to make the products appear trendy or essential to a modern lifestyle.
• Flavor Profiles: Employing candy-like flavors that appeal to younger demographics.
• Sleek Packaging: Using bright colors and modern, unobtrusive designs that do not resemble traditional tobacco products.

The WHO has highlighted that approximately 160 countries currently lack specific regulations for nicotine pouches. This regulatory vacuum leaves millions of young people vulnerable to products that are engineered to be easier to use and harder to quit than traditional tobacco.

Taking Action: A Global Perspective

Efforts to curb this trend are gaining momentum. Some jurisdictions are already implementing strict measures to protect their citizens. For instance, the city of Rio de Janeiro, Brazil, has taken significant steps to counter the use of these products by intensifying enforcement against sales and advertising, conducting coordinated inspections, and launching large-scale public awareness campaigns.

On May 19, the WHO recognized several leaders from around the world with the 2026 World No Tobacco Day Awards for their contributions to tobacco control. These efforts emphasize the importance of:

• Banning flavored nicotine products.
• Prohibiting advertising, promotion, and sponsorship.
• Ensuring indoor public places remain strictly smoke- and vape-free.
• Strengthening enforcement of existing tobacco control legislation.

Key Takeaways for Public Health

• Health Impact: Tobacco use is linked to cardiovascular disease, respiratory illness, and more than 20 types of cancer, resulting in over 7 million deaths annually.
• The Addiction Trap: Nicotine pouches and e-cigarettes are not proven to be effective tools for quitting tobacco at the population level; instead, they often serve as an entry point for nicotine addiction.
• Call to Action: The WHO urges users to take the first step toward quitting. Breaking free from nicotine addiction remains the most effective way to reduce the risk of tobacco-related illness.

As we observe World No Tobacco Day, the message is clear: protecting the health of the next generation requires a concerted effort to regulate these emerging products and hold the industry accountable for its marketing practices. If you or a loved one are struggling with nicotine dependence, consult a healthcare provider to discuss evidence-based cessation strategies.